Sheldon Sloan
Insider Reports History
- Location
- Waltham, MA
- Signature
- /s/ Heidy King-Jones, as Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Sheldon Sloan:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Spyre Therapeutics, Inc. | Chief Medical Officer | Common Stock | 0 | $0 | $50.00 | 01 Apr 2026 | Direct |
| Spyre Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 87,542 | 01 Apr 2026 | Direct |
Insider Reports Filed by Sheldon Sloan
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SYRE | Spyre Therapeutics, Inc. | 01 Apr 2026 | 3 | -$397,900 | 4 | Chief Medical Officer | 03 Apr 2026, 21:30 |
| SYRE | Spyre Therapeutics, Inc. | 09 Jan 2026 | 1 | $0 | 4 | Chief Medical Officer | 13 Jan 2026, 21:26 |
| SYRE | Spyre Therapeutics, Inc. | 15 Jan 2025 | 1 | $0 | 4 | Chief Medical Officer | 17 Jan 2025, 16:36 |
| SYRE | Spyre Therapeutics, Inc. | 01 Oct 2024 | 1 | $0 | 4 | Chief Medical Officer | 01 Oct 2024, 18:34 |
| SYRE | Spyre Therapeutics, Inc. | 01 Oct 2024 | 0 | $0 | 3 | Chief Medical Officer | 01 Oct 2024, 18:26 |